42 related articles for article (PubMed ID: 12006537)
1. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
Furihata M; Takeuchi T; Matsumoto M; Kurabayashi A; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
Clin Cancer Res; 2002 May; 8(5):1192-5. PubMed ID: 12006537
[TBL] [Abstract][Full Text] [Related]
2. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.
Storey A; Thomas M; Kalita A; Harwood C; Gardiol D; Mantovani F; Breuer J; Leigh IM; Matlashewski G; Banks L
Nature; 1998 May; 393(6682):229-34. PubMed ID: 9607760
[TBL] [Abstract][Full Text] [Related]
3. Primary structure polymorphism at amino acid residue 72 of human p53.
Matlashewski GJ; Tuck S; Pim D; Lamb P; Schneider J; Crawford LV
Mol Cell Biol; 1987 Feb; 7(2):961-3. PubMed ID: 3547088
[TBL] [Abstract][Full Text] [Related]
4. Hallmarks of cancer: the next generation.
Hanahan D; Weinberg RA
Cell; 2011 Mar; 144(5):646-74. PubMed ID: 21376230
[TBL] [Abstract][Full Text] [Related]
5. Structural biology of the tumor suppressor p53.
Joerger AC; Fersht AR
Annu Rev Biochem; 2008; 77():557-82. PubMed ID: 18410249
[TBL] [Abstract][Full Text] [Related]
6. Novel agents on the horizon for cancer therapy.
Ma WW; Adjei AA
CA Cancer J Clin; 2009; 59(2):111-37. PubMed ID: 19278961
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for SV40 in human cancer?
Poulin DL; DeCaprio JA
J Clin Oncol; 2006 Sep; 24(26):4356-65. PubMed ID: 16963733
[TBL] [Abstract][Full Text] [Related]
8. Two polymorphic variants of wild-type p53 differ biochemically and biologically.
Thomas M; Kalita A; Labrecque S; Pim D; Banks L; Matlashewski G
Mol Cell Biol; 1999 Feb; 19(2):1092-100. PubMed ID: 9891044
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of a human cell line transformed by DNA from human adenovirus type 5.
Graham FL; Smiley J; Russell WC; Nairn R
J Gen Virol; 1977 Jul; 36(1):59-74. PubMed ID: 886304
[TBL] [Abstract][Full Text] [Related]
10. R280T mutation of p53 gene promotes proliferation of human glioma cells through GSK-3β/PTEN pathway.
Lin C; Liang Y; Zhu H; Zhang J; Zhong X
Neurosci Lett; 2012 Oct; 529(1):60-5. PubMed ID: 22999923
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer.
Ottaiano A; Caraglia M; Di Mauro A; Botti G; Lombardi A; Galon J; Luce A; D'Amore L; Perri F; Santorsola M; Hermitte F; Savarese G; Tatangelo F; Granata V; Izzo F; Belli A; Scala S; Delrio P; Circelli L; Nasti G
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33096795
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of p53 and pp53 Ser
García-Iglesias MJ; Cuevas-Higuera JL; Bastida-Sáenz A; de Garnica-García MG; Polledo L; Perero P; González-Fernández J; Fernández-Martínez B; Pérez-Martínez C
BMC Vet Res; 2020 Jul; 16(1):239. PubMed ID: 32660487
[TBL] [Abstract][Full Text] [Related]
13. Regulators of Oncogenic Mutant TP53 Gain of Function.
Yamamoto S; Iwakuma T
Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30577483
[TBL] [Abstract][Full Text] [Related]
14. RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas.
López-Nieva P; Fernández-Navarro P; Vaquero-Lorenzo C; Villa-Morales M; Graña-Castro O; Cobos-Fernández MÁ; López-Lorenzo JL; Llamas P; González-Sanchez L; Sastre I; Pollan M; Malumbres M; Santos J; Fernández-Piqueras J
BMC Cancer; 2018 Apr; 18(1):430. PubMed ID: 29661169
[TBL] [Abstract][Full Text] [Related]
15. Association of p53 rs1042522, MDM2 rs2279744, and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population.
Chen R; Liu S; Ye H; Li J; Du Y; Chen L; Liu X; Ding Y; Li Q; Mao Y; Ai S; Zhang P; Ma W; Yang H
Sci Rep; 2015 Aug; 5():13300. PubMed ID: 26289323
[TBL] [Abstract][Full Text] [Related]
16. Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer.
Dahabreh IJ; Schmid CH; Lau J; Varvarigou V; Murray S; Trikalinos TA
Am J Epidemiol; 2013 Jun; 177(12):1317-25. PubMed ID: 23729685
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p53 protein in human tumors.
Inoue K; Kurabayashi A; Shuin T; Ohtsuki Y; Furihata M
Med Mol Morphol; 2012 Jun; 45(3):115-23. PubMed ID: 23001293
[TBL] [Abstract][Full Text] [Related]
18. High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study.
Kamat N; Khidhir MA; Jaloudi M; Hussain S; Alashari MM; Al Qawasmeh KH; Rannug U
BMC Cancer; 2012 Aug; 12():373. PubMed ID: 22928966
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.
Katkoori VR; Jia X; Shanmugam C; Wan W; Meleth S; Bumpers H; Grizzle WE; Manne U
Clin Cancer Res; 2009 Apr; 15(7):2406-16. PubMed ID: 19339276
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression.
Zhu ZZ; Liu B; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu GS
J Zhejiang Univ Sci B; 2008 Nov; 9(11):847-52. PubMed ID: 18988302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]